The new SARS-like coronavirus has spread around China since its outbreak in Wuhan - the capital of central China’s Hubei province. As of June 7, 2022, there were 2,785,848 active cases with symptoms in Greater China. The pandemic has caused a significant impact in the country's economy.

Fast-moving epidemic

In Wuhan, over 3.8 thousand deaths were registered in the heart of the outbreak. The total infection number surged on February 12, 2020 in Hubei province. After a change in official methodology for diagnosing and counting cases, thousands of new cases were added to the total figure. There is little knowledge about how the virus that originated from animals transferred to humans. While human-to-human transmission has been confirmed, other transmission routes through aerosol and fecal-oral are also possible. The deaths from the current virus COVID-19 (formally known as 2019-nCoV) has surpassed the toll from the SARS epidemic of 2002 and 2003.

Key moments in the Chinese coronavirus timeline

The doctor in Wuhan, Dr. Li Wenliang, who first warned about the new strain of coronavirus was silenced by the police. It was announced on February 7, 2020 that he died from the effects of the coronavirus infection. His death triggered a national backlash over freedom of speech on Chinese social media. On March 18, 2020, the Chinese government reported no new domestically transmissions for the first time after a series of quarantine and social distancing measures had been implemented. On March 31, 2020, the National Health Commission (NHC) in China started reporting the infection number of symptom-free individuals who tested positive for coronavirus. Before that, asymptomatic cases had not been included in the Chinese official count. China lifted ten-week lockdown on Wuhan on April 8, 2020. Daily life was returning slowly back to normal in the country. On April 17, 2020, health authorities in Wuhan revised its death toll, adding some 1,290 fatalities in its total count.

As of June 6, 2022, the novel coronavirus SARS-CoV-2 that originated in Wuhan, the capital of Hubei province in China, had infected over 2.1 million people and killed 14,612 in the country. Hong Kong is currently the region with the highest active cases in China.

From Wuhan to the rest of China

In late December 2019, health authorities in Wuhan detected several pneumonia cases of unknown cause. Most of these patients had links to the Huanan Seafood Market. With Chinese New Year approaching, millions of Chinese migrant workers travelled back to their hometowns for the celebration. Before the start of the travel ban on January 23, around five million people had left Wuhan. By the end of January, the number of infections had surged to over ten thousand. The death toll from the virus exceeded that of the SARS outbreak a few days later. On February 12, thousands more cases were confirmed in Wuhan after an improvement to the diagnosis method, resulting in another sudden surge of confirmed cases. On March 31, 2020, the National Health Commission (NHC) in China announced that it would begin reporting the infection number of symptom-free individuals who tested positive for coronavirus. On April 17, 2020, health authorities in Wuhan revised its death toll, adding 50 percent more fatalities. After quarantine measures were implemented, the country reported no new local coronavirus COVID-19 transmissions for the first time on March 18, 2020.

The overloaded healthcare system

In Wuhan, 28 hospitals were designated to treat coronavirus patients, but the outbreak continued to test China’s disease control system and most of the hospitals were soon fully occupied. To combat the virus, the government announced plans to build a new hospital swiftly. On February 3, 2020, Huoshenshan Hospital was opened to provide an additional 1,300 beds. Due to an extreme shortage of health-care professionals in Wuhan, thousands of medical staff from all over China came voluntarily to the epicenter to offer their support. After no new deaths reported for first time, China lifted ten-week lockdown on Wuhan on April 8, 2020. Daily life was returning slowly back to normal in the country.

China COVID-19: Confirmed Case: New Increase data was reported at 17.000 Person in 10 May 2020. This records an increase from the previous number of 14.000 Person for 09 May 2020. China COVID-19: Confirmed Case: New Increase data is updated daily, averaging 51.000 Person from Jan 2020 (Median) to 10 May 2020, with 112 observations. The data reached an all-time high of 15,152.000 Person in 12 Feb 2020 and a record low of 1.000 Person in 08 May 2020. China COVID-19: Confirmed Case: New Increase data remains active status in CEIC and is reported by National Health Commission. The data is categorized under China Premium Database’s Socio-Demographic – Table CN.GZ: COVID-19: No of Patient.

China recorded 99256991 Coronavirus Cases since the epidemic began, according to the World Health Organization (WHO). In addition, China reported 5226 Coronavirus Deaths. This dataset includes a chart with historical data for China Coronavirus Cases.

View daily updates and historical trends for China Coronavirus Cases Per Day. Source: Johns Hopkins Center for Systems Science and Engineering. Track econ…

The outbreak of the coronavirus COVID-19 pandemic has caused huge impacts on Chinese people's daily life. According to a survey among Chinese conducted between February and March in 2021, around 27 percent of respondents expected that they would never work in the home office after the pandemic. Meanwhile, approximately 11 percent of respondents expected to work from home at least three days a week in post coronavirus times.

Chinese prefectural level governments started to report daily confirmed COVID-19 cases online, starting from January 2020. The disclosures may contain the mobility, potential exposure scenario, epidemiological characteristics, and other useful information of individual cases. We organized a group of content coders since early March 2020, kept monitoring the information updates, manually extracted useful information from the public disclosures, and compiled these datasets.We welcome any form of collaborations with us and non-commercial reuse of our dataset. We highly encourage interested parties to examine the data, report errors in our coding, and help us to keep the data updated.The detailed data description can be found on SSRN preprint server https://dx.doi.org/10.2139/ssrn.3705815.

China COVID-19: Confirmed Case data was reported at 118,147.000 Person in 08 Jan 2023. This records an increase from the previous number of 104,874.000 Person for 07 Jan 2023. China COVID-19: Confirmed Case data is updated daily, averaging 978.500 Person from Feb 2020 (Median) to 08 Jan 2023, with 1068 observations. The data reached an all-time high of 118,147.000 Person in 08 Jan 2023 and a record low of 55.000 Person in 09 Jun 2020. China COVID-19: Confirmed Case data remains active status in CEIC and is reported by National Health Commission. The data is categorized under High Frequency Database’s Disease Outbreaks – Table CN.GZ: COVID-19: No of Patient.

Updated to May 13, 2021. World COVID-19 daily cases with basemap, starting from January 22, 2020.

COVID-19: Confirmed Case: Year to Date: Beijing data was reported at 40,767.000 Person in 08 Jan 2023. This records an increase from the previous number of 40,539.000 Person for 07 Jan 2023. COVID-19: Confirmed Case: Year to Date: Beijing data is updated daily, averaging 1,079.000 Person from Jan 2020 (Median) to 08 Jan 2023, with 1086 observations. The data reached an all-time high of 40,767.000 Person in 08 Jan 2023 and a record low of 2.000 Person in 19 Jan 2020. COVID-19: Confirmed Case: Year to Date: Beijing data remains active status in CEIC and is reported by National Health Commission. The data is categorized under High Frequency Database’s Disease Outbreaks – Table CN.GZ: COVID-19: No of Patient.

In a survey among U.S. companies operating in China conducted in June 2022, about 17 percent of respondents stated that due to China's COVID-19 control measures, the estimated value of paused, delayed, or canceled investment plans exceeded 50 million U.S. dollars. 27 percent of surveyed U.S. companies said that their investment value affected by COVID-19 was between 10 and 25 million U.S. dollars.

Context:

From World Health Organization - On 31 December 2019, WHO was alerted to several cases of pneumonia in Wuhan City, Hubei Province of China. The virus did not match any other known virus. This raised concern because when a virus is new, we do not know how it affects people.

So daily level information on the affected people can give some interesting insights when it is made available to the broader data science community.

Johns Hopkins University has made an excellent dashboard using the affected cases data. Data is extracted from the google sheets associated and made available here.

Edited:

Now data is available as csv files in the Johns Hopkins Github repository. Please refer to the github repository for the Terms of Use details. Uploading it here for using it in Kaggle kernels and getting insights from the broader DS community.

Content

2019 Novel Coronavirus (2019-nCoV) is a virus (more specifically, a coronavirus) identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China. Early on, many of the patients in the outbreak in Wuhan, China reportedly had some link to a large seafood and animal market, suggesting animal-to-person spread. However, a growing number of patients reportedly have not had exposure to animal markets, indicating person-to-person spread is occurring. At this time, it’s unclear how easily or sustainably this virus is spreading between people - CDC

This dataset has daily level information on the number of affected cases, deaths and recovery from 2019 novel coronavirus. Please note that this is a time series data and so the number of cases on any given day is the cumulative number.

The data is available from 22 Jan, 2020.

Here’s a polished version suitable for a professional Kaggle dataset description:

Dataset Description

This dataset contains time-series and case-level records of the COVID-19 pandemic. The primary file is covid_19_data.csv, with supporting files for earlier records and individual-level line list data.

Files and Columns

1. covid_19_data.csv (Main File)

This is the primary dataset and contains aggregated COVID-19 statistics by location and date.

• Sno – Serial number of the record
• ObservationDate – Date of the observation (MM/DD/YYYY)
• Province/State – Province or state of the observation (may be missing for some entries)
• Country/Region – Country of the observation
• Last Update – Timestamp (UTC) when the record was last updated (not standardized, requires cleaning before use)
• Confirmed – Cumulative number of confirmed cases on that date
• Deaths – Cumulative number of deaths on that date
• Recovered – Cumulative number of recoveries on that date

2. 2019_ncov_data.csv (Legacy File)

This file contains earlier COVID-19 records. It is no longer updated and is provided only for historical reference. For current analysis, please use covid_19_data.csv.

3. COVID_open_line_list_data.csv

This file provides individual-level case information, obtained from an open data source. It includes patient demographics, travel history, and case outcomes.

4. COVID19_line_list_data.csv

Another individual-level case dataset, also obtained from public sources, with detailed patient-level information useful for micro-level epidemiological analysis.

✅ Use covid_19_data.csv for up-to-date aggregated global trends.

✅ Use the line list datasets for detailed, individual-level case analysis.

Country level datasets:

If you are interested in knowing country level data, please refer to the following Kaggle datasets:

India - https://www.kaggle.com/sudalairajkumar/covid19-in-india

South Korea - https://www.kaggle.com/kimjihoo/coronavirusdataset

Italy - https://www.kaggle.com/sudalairajkumar/covid19-in-italy

Brazil - https://www.kaggle.com/unanimad/corona-virus-brazil

USA - https://www.kaggle.com/sudalairajkumar/covid19-in-usa

Switzerland - https://www.kaggle.com/daenuprobst/covid19-cases-switzerland

Indonesia - https://www.kaggle.com/ardisragen/indonesia-coronavirus-cases

Acknowledgements :

Johns Hopkins University for making the data available for educational and academic research purposes

MoBS lab - https://www.mobs-lab.org/2019ncov.html

World Health Organization (WHO): https://www.who.int/

DXY.cn. Pneumonia. 2020. http://3g.dxy.cn/newh5/view/pneumonia.

BNO News: https://bnonews.com/index.php/2020/02/the-latest-coronavirus-cases/

National Health Commission of the People’s Republic of China (NHC): http://www.nhc.gov.cn/xcs/yqtb/list_gzbd.shtml

China CDC (CCDC): http://weekly.chinacdc.cn/news/TrackingtheEpidemic.htm

Hong Kong Department of Health: https://www.chp.gov.hk/en/features/102465.html

Macau Government: https://www.ssm.gov.mo/portal/

Taiwan CDC: https://sites.google....

A data set on COVID-19 pandemic in China, which covers daily statistics of confirmed cases (new and cumulative), recoveries (new and cumulative) and deaths (new and cumulative) at city/county level. All data are extracted from Chinese government reports.

In past 24 hours, China, Asia had N/A new cases, N/A deaths and N/A recoveries.

COVID-19: Confirmed Case: Local: Hospitalized: Severe Case: Shanghai data was reported at 0.000 Person in 07 Dec 2022. This stayed constant from the previous number of 0.000 Person for 06 Dec 2022. COVID-19: Confirmed Case: Local: Hospitalized: Severe Case: Shanghai data is updated daily, averaging 0.000 Person from Apr 2022 (Median) to 07 Dec 2022, with 238 observations. The data reached an all-time high of 526.000 Person in 05 May 2022 and a record low of 0.000 Person in 07 Dec 2022. COVID-19: Confirmed Case: Local: Hospitalized: Severe Case: Shanghai data remains active status in CEIC and is reported by Shanghai Municipal Health Commission. The data is categorized under China Premium Database’s Socio-Demographic – Table CN.GZ: COVID-19: No of Patient: Local.

On March 10, 2023, the Johns Hopkins Coronavirus Resource Center ceased collecting and reporting of global COVID-19 data. For updated cases, deaths, and vaccine data please visit the following sources:Global: World Health Organization (WHO)U.S.: U.S. Centers for Disease Control and Prevention (CDC)For more information, visit the Johns Hopkins Coronavirus Resource Center.This feature layer contains the most up-to-date COVID-19 cases and latest trend plot. It covers China, Canada, Australia (at province/state level), and the rest of the world (at country level, represented by either the country centroids or their capitals)and the US at county-level. Data sources: WHO, CDC, ECDC, NHC, DXY, 1point3acres, Worldometers.info, BNO, state and national government health departments, and local media reports. . The China data is automatically updating at least once per hour, and non-China data is updating hourly. This layer is created and maintained by the Center for Systems Science and Engineering (CSSE) at the Johns Hopkins University. This feature layer is supported by Esri Living Atlas team and JHU Data Services. This layer is opened to the public and free to share. Contact us.

In a survey conducted in June 2022 among U.S. companies operating in China, more than half of respondents stated that the country's strict COVID-19 control measures impacted their business or investment plans. About a quarter of all companies surveyed claimed that their plans remained unaffected.

Data and Code for Prediction of the COVID-19 Epidemic Trends Based on SEIR and AI Models.Data include the number of confirmed cases of COVID-19, local population density, capital GDP, distance to Wuhan, average annual temperature, average annual rainfall of Chinese provinces (Except for Hong Kong, Macao and Taiwan) and migration population in Wuhan. Code include SEIR, DNN, RNN for prediction.

This study aims to examine the development trend of COVID-19 in China and propose a model to assess the impacts of various prevention and control measures in combating the COVID-19 pandemic. Using COVID-19 cases reported by the National Health Commission of China from January 2, 2020, to January 2, 2022, we established a Susceptible-Exposed-Infected-Asymptomatic-Quarantined-Vaccinated-Hospitalized-Removed (SEIAQVHR) model to calculate the COVID-19 transmission rate and Rt effective reproduction number, and assess prevention and control measures. Additionally, we built a stochastic model to explore the development of the COVID-19 epidemic. We modeled the incidence trends in five outbreaks between 2020 and 2022. Some important features of the COVID-19 epidemic are mirrored in the estimates based on our SEIAQVHR model. Our model indicates that an infected index case entering the community has a 50%–60% chance to cause a COVID-19 outbreak. Wearing masks and getting vaccinated were the most effective measures among all the prevention and control measures. Specifically targeting asymptomatic individuals had no significant impact on the spread of COVID-19. By adjusting prevention and control parameters, we suggest that increasing the rates of effective vaccination and mask-wearing can significantly reduce COVID-19 cases in China. Our stochastic model analysis provides a useful tool for understanding the COVID-19 epidemic in China.

This data record contains one dataset deta of 2019-nCOV in China.xlsx, in .xlsx file format.The dataset includes the following information (in 8 separate columns) on the novel coronavirus (2019-nCoV) infection cases in China:-total number of confirmed cases, -total number of suspected cases-total number of cured cases-total number of deaths-total number of new confirmed cases-total number of new suspected cases-total number of new cured cases-total number of new deathsThe number of cases are reported for each day from January 20th to February 21st 2020.Study background, aims and methodology: The 2019–20 coronavirus outbreak is an ongoing public health emergency of international concern involving coronavirus disease 2019 (COVID-19). At the end of December 2019, the epidemic of the novel coronavirus 2019-nCOV infection has spread from the initial place of Wuhan, Huibei province in China, resulting in an epidemic throughout China, with sporadic cases reported globally.The elderly, as well as people with primary diseases, are more likely to die from the infection. Children with chronic kidney disease (CKD), and children on dialysis, are vulnerable, due to their primary diseases and low immunity, especially those who suffer from long-term hormone, immunosuppressive therapy, and maintenance hemodialysis.The aim of this study was to analyse the epidemiological and clinical characteristics of the novel coronavirus, and to explore the infection prevention and control strategies of 2019-nCoV in children with chronic kidney disease (CKD) and children on dialysis.Data were collected from the 2019-nCoV management plan of the National Health Commission of the People’s Republic of China and relevant guidelines. Data on the COVID-19 cases in China, including the number of people, clinical characteristics, effective prevention and control measures from January 20th to February 21st, 2020, and statistical data on CKD in children were collected.